https://www.selleckchem.com/pr....oducts/cct241533-hyd
059). There were no significant differences in sites of metastatic disease or administration of systemic therapies. No significant differences in OS and CSS were observed based on NED detected by CgA. Reduced median survival time and increased cancer-related death in cases with focal NED generates the hypothesis of inferior outcomes among patients with documented DM. No significant differences in OS and CSS were observed based on NED detected by CgA. Reduced median survival time and increased cancer-related death in case
Me gusta
Comentario
Compartir
